J. Guiles

发表

In vitro characterization of a novel series of platelet-derived growth factor receptor tyrosine kinase inhibitors.

G. M. Briggs, A. Treasurywala, C. Weigelt, 1996, Biochemical pharmacology.

Review Anti-infectives Antipicornavirus compounds and their use as a common cold therapy

J. Guiles, 1997 .

Development of 4H-pyridopyrimidines: a class of selective bacterial protein synthesis inhibitors

U. Ochsner, J. Bullard, J. Guiles, 2012, Organic and medicinal chemistry letters.

New agents for Clostridium difficile-associated disease

I. Critchley, J. Guiles, Xicheng Sun, 2008, Expert opinion on investigational drugs.

Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.

T. Jarvis, N. Janjić, U. Ochsner, 2009, The Journal of antimicrobial chemotherapy.

Recent Development in the Treatment of Clostridium difficile Associated Disease (CDAD)

N. Janjić, J. Guiles, Xicheng Sun, 2008 .

The solid-phase synthesis of novel 14-membered macrocycles for high throughput screening

R. Rivero, J. Guiles, C. Lanter, 2004, Molecular Diversity.

WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.

R. J. Hill, C. Faltynek, D. Miller, 1995, Molecular pharmacology.

Novel inhibitors of potassium ion channels on human T lymphocytes.

A. Treasurywala, C. Weigelt, J. Guiles, 1995, Journal of medicinal chemistry.

Structures of four methyltetrazole-containing antiviral compounds in human rhinovirus serotype 14.

V. Giranda, D. Pevear, P. Felock, 1995, Acta crystallographica. Section D, Biological crystallography.

Asymmetric synthesis of benzoquinolizidines: a formal synthesis of (-)-emetine

A. Meyers, J. Guiles, 1991 .

Discovery and Analysis of 4H-Pyridopyrimidines, a Class of Selective Bacterial Protein Synthesis Inhibitors

T. Jarvis, N. Janjić, U. Ochsner, 2010, Antimicrobial Agents and Chemotherapy.

A convenient asymmetric synthesis of pyrrolo[2,1-a]isoquinolines

A. Meyers, J. Guiles, 1990 .

Chiral lithio formamidines : are they configurationally stable ?

Michael A. Gonzalez, J. Warmus, A. Meyers, 1991 .

Quinazolin-2-ylamino-quinazolin-4-ols as novel non-nucleoside inhibitors of bacterial DNA polymerase III.

F. Dean, N. Janjić, U. Ochsner, 2009, Bioorganic & medicinal chemistry letters.

Structure of PolC reveals unique DNA binding and fidelity determinants

T. Jarvis, N. Janjić, J. Bullard, 2008, Proceedings of the National Academy of Sciences.

Solid-Phase Suzuki Coupling for C−C Bond Formation

W. Murray, J. Guiles, Sigmond G. Johnson, 1996 .

Antibacterial Activity of REP8839, a New Antibiotic for Topical Use

N. Janjić, U. Ochsner, I. Critchley, 2005, Antimicrobial Agents and Chemotherapy.

Discovery and Analysis of 4 H -Pyridopyrimidines, a Class of Selective Bacterial Protein Synthesis Inhibitors (cid:1)

T. Jarvis, N. Janjić, U. Ochsner, 2010 .

Chiral formamidines. The mechanism of mono- and di-alkylation leading to chiral, non-racemic tetrahydroisoquinolines.

Michael A. Gonzalez, J. Warmus, A. Meyers, 1991 .

Chiral formamidines. Asymmetric synthesis of 1,1-disubstituted tetrahydroisoquinolines.

Michael A. Gonzalez, J. Warmus, A. Meyers, 1991 .

Novel inhibitors of the nuclear factor of activated T cells (NFAT)-mediated transcription of beta-galactosidase: potential immunosuppressive and antiinflammatory agents.

A. Treasurywala, C. Weigelt, Y. Baine, 1995, Journal of medicinal chemistry.

Grignard cross-coupling amenable to large scale production of alpha-fluorostyryl and alpha-fluorovinylthiophenes.

T. Tarasow, J. Guiles, J. Qiu, 2008, The Journal of organic chemistry.

Quinazolin-2-ylamino-quinazolin-4-ols as novel non-nucleoside inhibitors of bacterial DNA polymerase III.

F. Dean, N. Janjić, U. Ochsner, 2009, Bioorganic & medicinal chemistry letters.

Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.

T. Jarvis, N. Janjić, U. Ochsner, 2009, The Journal of antimicrobial chemotherapy.